← All stocks

AIM ImmunoTech Inc.

AIM Net buying
CIK 0000946644 #5330 in the set updated 21 Sep 2026
Bought (12 mo)
$13.46K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$13.46K
+$13.46K against sales at will

By person

7 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Equels Thomas K
CEO & President
$13.46K (4)
+$13.46K
126,822
$26.38K
KELLNER TED D
Director
1,969,504
$409.66K
+196,850%
MITCHELL WILLIAM M
Director
521,723
$108.52K
+93.9%
Rodino Peter W III
COO, Secretary, Gen. Counsel
401,762
$83.57K
+0.1%
APPELROUTH STEWART
Director
388,729
$80.86K
+62.1%
BRYAN NANCY
Director
291,882
$60.71K
+658.9%
CHEMEROW DAVID I.
Director
31,882
$6.63K

No percentages here. This company's share count has moved by a factor of 26.7 over the window, from 2,708,688 to 72,290,030 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Equels Thomas K
17 Sep 2026
CEO & President
Buy
24,000
$0.21
$4.99K
Equels Thomas K
16 Sep 2026
CEO & President
Buy
11,000
$0.21
$2.31K
Equels Thomas K
15 Sep 2026
CEO & President
Buy
22,000
$0.22
$4.86K
Equels Thomas K
14 Sep 2026
CEO & President
Buy
5,900
$0.22
$1.29K

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 52,800
History held since 1 Nov 2016